Search
for
Sort by
Research 361–390 of 1000+
- Dermatologic manifestations of endocrine disorders
- In Vivo Evaluation of<i>Eclipta alba</i>Extract as Anticancer and Multidrug Resistance Reversal Agent
- Hair loss
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Medications
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration
- Effect of N-acetylcysteine on hair follicle changes in mouse model of cyclophosphamide-induced alopecia: histological and biochemical study
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expression
- Lymphomatoid granulomatosis
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- TONGUE, RED
- Drug-Induced Hair Changes
- Cytostatics and immunosuppressive drugs
- Supportive Cryotherapy: A Review From Head to Toe
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Retinoids and hair growth
- Prophylaxis and Management of Skin Toxicities
- Medical Dermatology
- Anagen Effluvium in Association With Extracorporeal Membrane Oxygenation
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- Abstracts Pt.30
- Cutaneous signals of immune system disease
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases